Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here
Friday, January 25, 2013
Clinics reach out to Oakland’s Asian community to prevent “silent killer” hepatitis B
Hepatitis B, which is caused by the hepatitis B virus (HBV), is transmitted through blood and during childbirth. It ultimately leads to cirrhosis or liver cancer, and nearly 600,000 people worldwide die each year from the disease. In the United States, liver cancer resulting from chronic hep B is the second cause of cancer death among Asian men.